1. Home
  2. LOAN vs SER Comparison

LOAN vs SER Comparison

Compare LOAN & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Manhattan Bridge Capital Inc

LOAN

Manhattan Bridge Capital Inc

HOLD

Current Price

$4.76

Market Cap

51.9M

Sector

Real Estate

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$3.47

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOAN
SER
Founded
1989
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.9M
42.0M
IPO Year
1999
2018

Fundamental Metrics

Financial Performance
Metric
LOAN
SER
Price
$4.76
$3.47
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
41.6K
17.1K
Earning Date
10-24-2025
11-13-2025
Dividend Yield
9.85%
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$7,138,128.00
$116,000.00
Revenue This Year
N/A
$134.46
Revenue Next Year
$4.47
N/A
P/E Ratio
$10.09
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.29
$3.34
52 Week High
$6.05
$7.92

Technical Indicators

Market Signals
Indicator
LOAN
SER
Relative Strength Index (RSI) 44.58 32.85
Support Level $4.64 $3.68
Resistance Level $4.74 $4.26
Average True Range (ATR) 0.16 0.26
MACD 0.04 -0.01
Stochastic Oscillator 62.51 3.76

Price Performance

Historical Comparison
LOAN
SER

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: